Robot-Assisted breast reconstruction: smaller incisions, big hopes

NCT ID NCT07222514

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a single-port robotic system can safely harvest tissue from the abdomen for breast reconstruction. Four women who need DIEP flap reconstruction will undergo the procedure. The goal is to see if the robotic approach is feasible and leads to fewer complications and smaller scars.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Single-Port Robotic System

What this could lead to

If successful, this could make DIEP flap breast reconstruction less invasive, with smaller incisions and potentially faster recovery.

What could go wrong

This is a very early feasibility study with only 4 participants, so results may not apply broadly. Risks include surgical complications like flap failure or infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••